MAPT and synucleinopathy: While prospective studies can identify PNS-related symptoms, the message of finding PNS-tau pathology is more to support the notion that detection of misfolded tau in the PNS can be a target for biomarker development, such as implemented for the α-synucleinopathies, for example using skin biopsies.